Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fernando

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Plos Neglected Tropical Diseases|April 16, 2015
Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infectionChandima Jeewandara, Thiruni N Adikari, Laksiri Gomes, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinomaBrian G Czito, Chris R Kelsey, Herbert I Hurwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial resultsBrian G Czito, Christopher G Willett, Johanna C Bendell, et al.
Cancer|June 16, 2018
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancerHanna K Sanoff, Richard M Goldberg, Anastasia Ivanova, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Plos Neglected Tropical Diseases|April 16, 2015
Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infectionChandima Jeewandara, Thiruni N Adikari, Laksiri Gomes, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
A Phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinomaBrian G Czito, Chris R Kelsey, Herbert I Hurwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial resultsBrian G Czito, Christopher G Willett, Johanna C Bendell, et al.
Cancer|June 16, 2018
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancerHanna K Sanoff, Richard M Goldberg, Anastasia Ivanova, et al.
Pageof 8